Company / Cash per Share
Pfizer Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.20
FY2025
5-year range
$0.07 / $0.50
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#194 of 205
Health Care
What the data says
Among 205 Health Care companies, Pfizer is in the bottom 5% for cash per share. Cash per Share has fluctuated over the past 10 years, ranging from $0.07 in FY2022 to $0.52 in FY2016.
Based on SEC 10-K filings.
0.20 in FY2025 with a 5-year CAGR of -7.7%.
Declined from $0.50 to $0.20 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +39.4%
- 5-Year CAGR
- -7.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 205This company $0.20 Sector average $72.93
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 10.0% year-over-year.
- Ranks #194 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.20 | +10.0% |
| FY2024 | $0.18 | -63.6% |
| FY2023 | $0.50 | +576.7% |
| FY2022 | $0.07 | -78.4% |
| FY2021 | $0.34 | +14.6% |
| FY2020 | $0.30 | +61.5% |
| FY2019 | $0.19 | +0.1% |
| FY2018 | $0.18 | -13.8% |
| FY2017 | $0.21 | -58.8% |
| FY2016 | $0.52 | -1.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026